• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TRICLIP G4 SYSTEM; TRICUSPID VALVE REPAIR DEVICE, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TRICLIP G4 SYSTEM; TRICUSPID VALVE REPAIR DEVICE, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number TCDS0301-XT
Medical Device Problem Code Incomplete Coaptation (2507)
Health Effect - Clinical Code Tricuspid Valve Insufficiency/ Regurgitation (4453)
Date of Event 12/20/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device remains implanted in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that on (b)(6) 2024, a triclip procedure was performed to treat functional tricuspid regurgitation (tr) with a grade of 5.Two clips were implanted, reducing tr to a grade of 1.At the one month follow-up appointment, echocardiography showed the implanted clips had detached from the septal leaflet (single leaflet device attachment/slda), causing tr to increase to a grade of 4.
 
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot-specific quality issue.Based on available information, the cause of the reported slda was unable to be determined.Tricuspid valve insufficiency/ regurgitation appears to be due to the slda.Tricuspid valve insufficiency/ regurgitation is listed in the instructions for use as a known possible complication associated with the triclip procedures.The reported serious injury/illness/impairment was a result of case specific circumstance.There is no indication of a product quality issue with respect to manufacture, design, or labeling.C.
 
Event or Problem Description
It was reported that on (b)(6) 2024, a triclip procedure was performed to treat functional tricuspid regurgitation (tr) with a grade of 5.Two clips were implanted, reducing tr to a grade of 1.At the one month follow-up appointment, echocardiography showed the implanted clips had detached from the septal leaflet (single leaflet device attachment/slda), causing tr to increase to a grade of 4.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRICLIP G4 SYSTEM
Common Device Name
TRICUSPID VALVE REPAIR DEVICE, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key22416882
Report Number2135147-2025-03684
Device Sequence Number12537763
Product Code NPS
UDI-Device Identifier05415067047731
UDI-Public(01)05415067047731(17)250925(10)40925R1003
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
P230007
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/28/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/25/2025
Device Model NumberTCDS0301-XT
Device Catalogue NumberTCDS0301-XT
Device Lot Number40925R1003
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/12/2025
Supplement Date Received by Manufacturer07/23/2025
Initial Report FDA Received Date07/07/2025
Supplement Report FDA Received Date07/28/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/26/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-